268 related articles for article (PubMed ID: 18774728)
21. Primary mediastinal large B-cell lymphoma.
Faris JE; LaCasce AS
Clin Adv Hematol Oncol; 2009 Feb; 7(2):125-33. PubMed ID: 19367254
[TBL] [Abstract][Full Text] [Related]
22. [Large-cell mediastinal lymphoma].
Gori E; Tata F; Zanna M; Bruzzone G
Clin Ter; 1991 Oct 15-31; 139(1-2):45-8. PubMed ID: 1837766
[TBL] [Abstract][Full Text] [Related]
23. Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients.
Sar A; Perizzolo M; Stewart D; Mansoor A; Difrancesco LM; Demetrick DJ
Leuk Res; 2009 Jun; 33(6):792-7. PubMed ID: 19054557
[TBL] [Abstract][Full Text] [Related]
24. [Efficacy of conservative treatment of gastric lymphosarcoma].
Zvonkov EE; Kremenetskaia AM; Kravchenko SK; Makhinia VA; Kaplanskaia IB; Obukhova TN; Samoĭlova RS; Shevelev AA; Magomedova AU; Bariakh EA; Krasil'nikova BB; Gubkin AV; Iliushkina EA; Mar'in DS; Morozova AK; Kulikov SM; Gemdzhian EG; Vorob'ev AI
Ter Arkh; 2008; 80(7):18-26. PubMed ID: 18763589
[TBL] [Abstract][Full Text] [Related]
25. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
26. MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.
Hsi ED; Sup SJ; Alemany C; Tso E; Skacel M; Elson P; Alonso MA; Pohlman B
Am J Clin Pathol; 2006 May; 125(5):776-82. PubMed ID: 16707382
[TBL] [Abstract][Full Text] [Related]
27. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
[TBL] [Abstract][Full Text] [Related]
28. Primary mediastinal B-cell lymphoma.
Boleti E; Johnson PW
Hematol Oncol; 2007 Dec; 25(4):157-63. PubMed ID: 17575573
[TBL] [Abstract][Full Text] [Related]
29. CD23 expression in mediastinal large B-cell lymphomas.
Calaminici M; Piper K; Lee AM; Norton AJ
Histopathology; 2004 Dec; 45(6):619-24. PubMed ID: 15569053
[TBL] [Abstract][Full Text] [Related]
30. Primary mediastinal large B-cell lymphoma is an important differential among mediastinal tumours.
Maryniak RK; Roszkowska-Purska K
Pol J Pathol; 2002; 53(3):139-44. PubMed ID: 12476616
[TBL] [Abstract][Full Text] [Related]
31. [A case report of mediastinal malignant lymphoma with long survival following combination chemotherapy using adriamycin, vincristine and cyclophosphamide].
Koshiishi Y; Amemiya R; Matsushima Y; Taira O; Takizawa N; Oho K; Hayata Y; Serizawa H
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Mar; 28(3):499-503. PubMed ID: 2214391
[TBL] [Abstract][Full Text] [Related]
32. Treatment of primary mediastinal large B cell lymphoma with an alternating chemotherapy regimen based on high-dose methotrexate.
Fietz T; Knauf WU; Hänel M; Franke A; Freund M; Thiel E;
Ann Hematol; 2009 May; 88(5):433-9. PubMed ID: 18853160
[TBL] [Abstract][Full Text] [Related]
33. [Large B cell lymphoma of the mediastinum. 6 cases].
Wurtz A; Chambon JP; Fenaux P; Bauters F; Gosselin B
Ann Chir; 1989; 43(2):165-70. PubMed ID: 2653164
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of diffuse large B-cell lymphoma].
Gleissner B; Zwick C; Pfreundschuh M
Dtsch Med Wochenschr; 2008 Sep; 133(36):1785-94; quiz 1795-6. PubMed ID: 18767006
[TBL] [Abstract][Full Text] [Related]
35. [Primary mediastinal (thymic) large B-cell lymphoma: review of the literature and author's own data].
Kichigina MIu; Tumian GS; Kovrigina AM; Trofimova OP; Larionova VB; Chekan AA; Bykov DA; Osmanov DSh
Ter Arkh; 2011; 83(7):38-46. PubMed ID: 21894750
[TBL] [Abstract][Full Text] [Related]
36. Estimation of the relationship between caspase-3 expression and clinical outcome of Burkitt's and Burkitt-like lymphoma.
Nomura Y; Yoshida S; Karube K; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
Cancer Sci; 2008 Aug; 99(8):1564-9. PubMed ID: 18754867
[TBL] [Abstract][Full Text] [Related]
37. A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy.
Tucci A; Ferrari S; Bottelli C; Borlenghi E; Drera M; Rossi G
Cancer; 2009 Oct; 115(19):4547-53. PubMed ID: 19562776
[TBL] [Abstract][Full Text] [Related]
38. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
39. Advances in the treatment of hematologic malignancies. Part 1 of a 3-part series: Aggressive lymphomas.
Fisher RI; Coiffier B; Vose JM
Clin Adv Hematol Oncol; 2006 Apr; 4(4):suppl 1, 4-9; discussion suppl 10; quiz 2 p following suppl 10. PubMed ID: 16775878
[TBL] [Abstract][Full Text] [Related]
40. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome.
Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH
Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
